Atogepant for migraine in real-world clinical practice: Insights from a large multicentre study in a treatment-resistant population (GEMA project)

Gago-Veiga, Ana Beatriz López-Rodríguez, Ana Belén Sánchez Jiménez, Marina Iglesias Rubio, Álvaro Montes, Nuria Camiña Muñiz, Javier Domínguez Gallego, Marta Calle de Miguel, Carlos Latorre, Germán Rodríguez-Vico, Jaime Jaimes, Alex Gómez García, Andrea Urtiaga, Sara González Salaices, Marta Dileone, Michele González-García, Nuria Porta-Etessam, Jesús Cuadrado, María-Luz Herrero San-Martín, Alejandro Guerrero-Peral, Ángel-Luis González-Osorio, Yesica Casas-Limón, Javier Sánchez-Soblechero, Antonio Lozano-Ros, Alberto Díaz-De-Terán, Javier Portocarrero-Sánchez, Leonardo Molina-Martínez, Francisco-José Santos-Lasaosa, Sonia Martín-Ávila, Guillermo Riva, Elena Fernández-Lázaro, Iris Atogepant for migraine in real-world clinical practice: Insights from a large multicentre study in a treatment-resistant population (GEMA project)

Cephalalgia

10.1177/03331024261431337 2026

2026